Moreover, CACE can alleviate lipid metabolism disorder through inhibiting ER stress via PERK and ATF6 signaling pathways and activating PPARs with upregulating PPARα expression and downregulating PPARγ expression. Here, EIF2AK3 is linked to Disorder of lipid metabolism.